Your Current Location : Fund Card : Portfolio Classification |
|
|
|
Axis NIFTY Healthcare ETF Reg (G) |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
0.02 |
Equity |
99.77 |
Trep |
0.21 |
|
|
Concentration Analysis |
Top 5 Holdings |
60.79% |
Top 10 Holdings |
82.76% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
79.7 |
Healthcare |
20.07 |
Cash |
0.23 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.39 |
PE Ratio |
40.16 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
23.48 |
Cipla Limited |
10.54 |
Dr Reddys Laboratories Limited |
10.06 |
Apollo Hospitals Enterprise Limited |
8.59 |
Max Healthcare Institute Limited |
8.12 |
DIVI LABORATORIES LTD |
5.89 |
Lupin Limited |
5.23 |
Aurobindo Pharma Limited |
4.11 |
Zydus Lifesciences Limited |
3.41 |
Alkem Laboratories Limited |
3.33 |
Torrent Pharmaceuticals Limited |
3.16 |
IPCA Laboratories Limited |
2.23 |
Laurus Labs Limited |
2.05 |
Abbott India Limited |
1.94 |
Glenmark Pharmaceuticals Limited |
1.92 |
Syngene International Limited |
1.69 |
Biocon Limited |
1.57 |
Dr Lal Path Labs Limited |
1.09 |
Granules India Limited |
0.78 |
Metropolis Healthcare Limited |
0.58 |
Clearing Corporation of India Ltd |
0.21 |
Net Receivables / (Payables) |
0.02 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
|
|
|
|
|